Exercise of Options
Updated : 15:59
Spectra Systems Corporation
(the "Company")
Exercise of Options
Spectra Systems Corporation, a leader in machine-readable high speed banknote authentication, brand protection technologies, and gaming security software, announces the exercise of options by an employee of Spectra.
The employee has exercised options over 13,339 shares of common stock of $0.01 each in the Company ("Shares") with an exercise price of 25p per share on 16 December 2024. The employee has elected to utilize the net cashless exercise feature and has therefore surrendered 1,339 shares to the Company. Accordingly, the employee will be issued 12,000 shares.
The shares being issued are restricted securities as defined in Rule 144 of the US Securities Act of 1933 and have been issued pursuant to an exemption from registration under Rule 701 promulgated under the US Securities Act of 1933.
Accordingly, the Company has issued and will apply for 12,000 Shares to be admitted to trading on AIM, which is expected to take place on or around 24 December 2024 ("Admission").The Company's issued share capital now comprises:
571,380 shares in the Regulation S stock line ISIN number USU8457D1091 (AIM:SPSC); and
47,669,592 shares in the unrestricted line ISIN number US84756T1060 (AIM:SPSY).
Spectra Systems has no Shares in treasury, therefore 48,240,972 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.
Enquiries:
Spectra Systems Corporation Dr. Nabil Lawandy, Chief Executive Officer
| Tel: +1 (0)401 274 4700
|
Zeus (Nominated Adviser and Broker) Chris Fielding (Director, Investment Banking) James Bavister (Assistant Director) Andrew de Andrade (Associate, Corporate Finance)
Allenby Capital Limited (Joint Broker) Nick Naylor/James Reeve (Corporate Finance) Amrit Nahal (Sales and Corporate Broking) | Tel: +44 (0)20 3829 5000
Tel: +44 (0)20 3328 5665 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.